Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis

Frontiers in Physiology

Volumn 3 SEP, Issue , 2012, Pages

  d'Amaro, Rocca ^a   Scheidegger, Rolf ^a   Blumer, Susan ^a   Pazera, Pawel ^a   Katsaros, Christos ^a   Graf, Daniel ^b   Chiquet, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bone morphogenetic protein; Extracellular matrix; Fibrillin1; Fibronectin; Growth factors; Palate morphogenesis; Tenascin; Transforming growth factor beta

Indexed keywords

EID: 84867156445     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00377     Document Type: Article

References (53)

1. Alappat, S., Zhang, Z. Y., and Chen, Y. P. (2003). Msx homeobox gene family and craniofacial development. Cell Res. 13, 429-442.
2. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2008). Molecular Biology of the Cell, 5th Edn. chapter 19. New York, NY: Garland Science.
3. Aufderheide, E., and Ekblom, P. (1988). Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelialmesenchymal interactions. J. Cell Biol. 107, 2341-2349.
4. Brellier, F., Martina, E., Chiquet, M., Ferralli, J., van der Heyden, M., Orend, G., Schittny, J. C., Chiquet-Ehrismann, R., and Tucker, R. P. (2012). The adhesion modulating properties of tenascin-W. Int. J. Biol. Sci. 8, 187-194.
5. Chiquet-Ehrismann, R., and Chiquet, M. (2003). Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200, 488-499.
6. Chiquet-Ehrismann, R., Kalla, P., Pearson, C. A., Beck, K., and Chiquet, M. (1988). Tenascin interferes with fibronectin action. Cell 53, 383-390.
7. Dallas, S. L., Sivakumar, P., Jones, C. J., Chen, Q., Peters, D. M., Mosher, D.F., Humphries, M.J.,andKielty, C. M. (2005). Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J. Biol. Chem. 280, 18871-18880.
8. Ferguson, M. W. (1988). Palate development. Development 103(Suppl.), 41-60.
9. Fluck, M., Tunc-Civelek, V., and Chiquet, M. (2000). Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J. Cell Sci. 113(Pt 20), 3583-3591.
10. Fontana, L., Chen, Y., Prijatelj, P., Sakai, T., Fassler, R., Sakai, L. Y., and Rifkin, D. B. (2005). Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 19, 1798-1808.
11. Forsberg, E., Hirsch, E., Frohlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S., and Fassler, R. (1996). Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. U.S.A. 93, 6594-6599.
12. Gato, A., Martinez, M. L., Tudela, C., Alonso, I., Moro, J. A., Formoso, M. A., Ferguson, M. W., and Martinez-Alvarez, C. (2002). TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev. Biol. 250, 393-405.
13. Gritli-Linde, A. (2007). Molecular control of secondary palate development. Dev. Biol. 301, 309-326.
14. Huang, W., Chiquet-Ehrismann, R., Moyano, J. V., Garcia-Pardo, A., and Orend, G. (2001). Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 61, 8586-8594.
15. Huang, X., Yokota, T., Iwata, J., and Chai, Y. (2011). Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis. J. Dent. Res. 90, 981-987.
16. Ingraham, C. R., Kinoshita, A., Kondo, S., Yang, B., Sajan, S., Trout, K. J., Malik, M. I., Dunnwald, M., Goudy S.L., Lovett, M., Murray, J.C., and Schutte, B. C. (2006). Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat. Genet. 38, 1335-1340.
17. Iozzo, R. V., Zoeller, J. J., and Nystrom, A. (2009). Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol. Cells 27, 503-513.
18. Iwata, J., Parada, C., and Chai, Y. (2011). The mechanism of TGFbeta signaling during palate development. Oral Dis. 17, 733-744.
19. Jugessur, A., and Murray, J. C. (2005). Orofacial clefting: recent insights into a complex trait. Curr. Opin. Genet. Dev. 15, 270-278.
20. Kaartinen, V., and Warburton, D. (2003). Fibrillin controls TGF-beta activation. Nat. Genet. 33, 331-332.
21. Keene, D. R., Maddox, B. K., Kuo, H. J., Sakai, L. Y., and Glanville, R. W. (1991). Extraction of extendable beaded structures and their identification as fibrillin-containing extracellular matrix microfibrils. J. Histochem. Cytochem. 39, 441-449.
22. Koch, M., Bohrmann, B., Matthison M., Hagios, C., Trueb, B.,and Chiquet, M. (1995). Large and small splice variants of collagen XII: differential expression and ligand binding. J. Cell Biol. 130, 1005-1014.
23. Kondo, S., Schutte, B. C., Richardson, R. J., Bjork, B. C., Knight, A. S., Watanabe, Y., Howard, E., de Lima, R. L., Daack-Hirsch, S., Sander, A., McDonald-McGinn, D. M., Zackai, E. H., Lammer, E. J., Aylsworth, A. S., Ardinger, H. H., Lidral, A. C., Pober, B. R., Moreno, L., Arcos-Burgos, M., Valencia, C., Houdayer, C., Bahuau, M., MorettiFerreira, D., Richieri-Costa, A., Dixon, M. J., and Murray, J. C. (2002). Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet. 32, 285-289.
24. Larsen, M., Artym, V. V., Green, J. A., and Yamada, K. M. (2006). The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 18, 463-471.
25. Lee, B., Godfrey, M., Vitale, E., Hori, H., Mattei, M. G., Sarfarazi, M., Tsipouras, P., Ramirez, F., and Hollister, D. W. (1991). Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352, 330-334.
26. Maier, S., Lutz, R., Gelman, L., Sarasa Renedo, A., Schenk, S., Grashoff, C., and Chiquet, M. (2008). Tenascin-C induction by cyclic strain requires integrin-linked kinase. Biochim. Biophys. Acta 1783, 1150-1162.
27. Martinez-Alvarez, C., Tudela, C., Perez Miguelsanz, J., O'Kane, S., Puerta, J., and Ferguson, M. W. (2000). Medial edge epithelial cell fate during palatal fusion. Dev. Biol. 220, 343-357.
28. Martinez-Sanz, E., Del Rio, A., Barrio, C., Murillo, J., Maldonado E., Garcillan, B., Amoros, M., Fuerte, T., Fernandez, A., Trinidad, E., Rabadan, M. A., Lopez, Y. Martinez, M.L., and Martinez-Alvarez, C. (2008). Alteration of medial-edge epithelium cell adhesion in two Tgf-beta3 null mouse strains. Differentiation 76, 417-430.
29. Meng, L., Bian, Z., Torensma, R., and Von den Hoff, J. W. (2009). Biological mechanisms in palatogenesis and cleft palate. J. Dent. Res. 88, 22-33.
30. Mitchell, L. E. (2009). Epidemiology of Cleft Lip and Palate. In Comprehensive Cleft Care. Toronto, ON: McGraw-Hill.
31. Morris-Wiman, J., and Brinkley, L. (1992). An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling. Anat. Rec. 234, 575-586.
32. Mossey, P. A., Little, J., Munger, R. G., Dixon, M.J.,andShaw, W.C. (2009). Cleft lip and palate. Lancet 374, 1773-1785.
33. Mott, J. D., and Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
34. Nawshad, A. (2008). Palatal seam disintegration: to die or not to die? that is no longer the question. Dev. Dyn. 237, 2643-2656.
35. Nawshad, A., and Hay, E. D. (2003). TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J. Cell Biol. 163, 1291-1301.
36. Nawshad, A., LaGamba, D., and Hay, E. D. (2004). Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch. Oral Biol. 49, 675-689.
37. Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., and Dietz, H. C. (2003). Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407-411.
38. Nistala, H., Lee-Arteaga, S., Smaldone, S., Siciliano, G., Carta, L., Ono, R. N., Sengle, G., Arteaga-Solis, E., Levasseur, R., Ducy, P., Sakai, L. Y., Karsenty, G.,andRamirez, F. (2010). Fibrillin-1 and -2 differentially modulate endogenous TGFbeta and BMP bioavailability during bone formation. J. Cell Biol. 190, 1107-1121.
39. Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W., and Doetschman, T. (1995). Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11, 409-414.
40. Ramirez, F., and Rifkin, D. B. (2009). Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 21, 616-622.
41. Ramirez, F., and Sakai, L. Y. (2010). Biogenesis and function of fibrillin assemblies. Cell Tissue Res. 339, 71-82.
42. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., and Aizawa, S. (1992). Mice develop normally without tenascin. Genes Dev. 6, 1821-1831.
43. Satokata, I., and Maas, R. (1994). Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 6, 348-356.
44. Scherberich, A., Tucker, R. P., Samandari, E., Brown-Luedi M., Martin, D.,andChiquet Ehrismann, R. (2004). Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J. Cell Sci. 117, 571-581.
45. Taya, Y., O'Kane, S.,andFerguson, M. W. (1999). Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126, 3869-3879.
46. Tucker, R. P., and Chiquet-Ehrismann, R. (2009). The regulation of tenascin expression by tissue microenvironments. Biochim. Biophys. Acta 1793, 888-892.
47. Verrecchia, F., and Mauviel, A. (2007). Transforming growth factor-beta and fibrosis. World J. Gastroenterol. 13, 3056-3062.
48. Wipff, P. J., Rifkin, D. B., Meister, J. J., and Hinz, B. (2007). Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323.
49. Wyatt, A. W., Osborne, R. J., Stewart, H., and Ragge, N. K. (2010). Bone morphogenetic protein 7 (BMP7) mutations are associated with variable ocular, brain, ear, palate, and skeletal anomalies. Hum. Mutat. 31, 781-787.
50. Xu, X., Han, J., Ito, Y., Bringas, P. Jr., Urata, M. M., and Chai, Y. (2006). Cell autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal fusion. Dev. Biol. 297, 238-248.
51. Zhang, G., Young, B.B., Ezura, Y., Favata, M., Soslowsky, L. J., Chakravarti, S., and Birk, D. E. (2005). Development of tendon structure and function: regulation of collagen fibrillogenesis. J. Musculoskelet. Neuronal Interact. 5, 5-21.
52. Zouvelou, V., Luder, H.U., Mitsiadis, T. A., and Graf, D. (2009a). Deletion of BMP7 affects the development of bones, teeth, and other ectodermal appendages of the orofacial complex. J. Exp. Zool. B, Mol. Dev. Evol. 312B, 361-374.
53. Zouvelou, V., Passa, O., Segklia, K., Tsalavos, S., Valenzuela, D. M. Economides, A.N.,andGraf, D. (2009b). Generation and functional characterization of mice with a conditional BMP7 allele. Int. J. Dev. Biol. 53, 597-603.